ALT vs PG · rev $20.0K vs P/E 25, rev $84.28B
Altimmune Inc (ALT) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
ALT currently screens at market cap $527.0M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the ALT and PG stock pages for the full models.
Not investment advice.